Evidence map›Paper›PMID 40024924›Full record

ArticleJournal of neurology2025

Taste impairment in patients with Parkinsonism.

Qingyong Zhu, Han Liu, Jiuqi Wang, Renyi Feng, Mingming Ma, Xuejing Wang, Xuebing Ding

Abstract read
In one paragraph

Article in Journal of neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Qingyong Zhu *Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Han Liu *Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Jiuqi WangDepartment of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Renyi FengDepartment of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Mingming MaDepartment of Neurology, Henan Provincial People's Hospital, Zhengzhou, China.
Xuejing WangDepartment of Neurology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
Xuebing DingDepartment of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. dingxb6@mail.sysu.edu.cn.

Funding

First Affiliated Hospital of Zhengzhou University QNCXTD2023008National Natural Science Foundation of China 82171248National Natural Science Foundation of China 82471350Natural Science Foundation of Henan Province for Distinguished Young Scholars 222300420017
6 · The paper itself

Abstract

backgroundTaste impairment is a prevalent issue among individuals with idiopathic Parkinson's disease (iPD). However, understanding taste disorders among different Parkinsonism remains incomplete. Our objective was to assess the incidence and severity of taste responses to sweet, salty, sour, bitter, and umami substances in patients with iPD, progressive supranuclear palsy (PSP), and multiple system atrophy (MSA).

methodsTaste function was evaluated by assessing the intensity ratings of four concentrations of sweet, salty, sour, bitter, and umami in 221 healthy controls (HCs), 251 iPD patients, 156 PSP patients, and 60 MSA patients. The Kruskal-Wallis one-way analysis was employed to discern differences in taste function among groups. Logistic regression models were utilized to analyze the association between disease severity and taste function.

resultsParticipants with iPD, PSP, and MSA exhibited lower total taste scores (TTS) compared to HCs (P < 0.0001, P < 0.0001, and P = 0.0002, respectively). The TTS was significantly lower in iPD patients compared to PSP and MSA patients (P = 0.0024 and P = 0.0464, respectively), with no discernible difference between PSP and MSA patients (P = 0.9998). Furthermore, in patients with iPD, both disease severity and gastrointestinal function exhibited a significant negative correlation with the TTS. However, the taste test lacked the potency to reliably distinguish iPD from PSP and MSA.

conclusionsThese research findings suggest that taste impairment emerges as a phenotype of Parkinsonism, serving as a basis for differential diagnosis and guiding dietary adjustments for patients.

Indexed as

Multiple System AtrophyParkinson DiseaseParkinsonian DisordersSupranuclear Palsy, ProgressiveTaste DisordersAgedFemaleHumansMaleMiddle AgedSeverity of Illness IndexiPDMSAPSPTaste impairment

Identifiers

PMID40024924
PMCPMC11872754

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.